U.S. FDA Issues Draft Guidance For Abuse-Deterrent Opiod Generics

The U.S. Food and Drug Administration issued draft guidance on Thursday for abuse-deterrent opioid generics, including a recommendation that studies be conducted to demonstrate that generic opioids are no less abuse-deterrent than branded drugs.

The FDA said it was encouraging industry efforts to develop pain medicines that are more difficult to abuse. The regulator issued guidelines to support increased development of generic versions of approved opioids with abuse-deterrent formulations. (1.usa.gov/1LJv02w) To read more on this ongoing story, check out the article titled, "U.S. FDA Issues Draft Guidance For Abuse-Deterrent Opiod Generics" courtesy of Reuters.

 

HORIZON Health Ventures is a healthcare cost management solutions company used by insurance brokers, employee benefit consultants, third-party administrators, insurance companies, and associations, to bring proven thought leadership and strategy to the management of their clients healthcare costs. To learn more about HHV and their services, please visit http://horizonhealthventures.com/